Lexaurin

Bromazepam, the active ingredient in Lexaurin, is a benzodiazepine presented as an oral dosage form for oral use. It is indicated for the management of anxiety disorders and provides short‑term relief of anxiety symptoms in adults. GNH USA supplies Lexaurin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Bromazepam acts on the central nervous system to alleviate anxiety‑related conditions. - Anxiety disorders: reduces excessive worry and tension in patients with generalized anxiety. - Acute anxiety episodes: provides rapid, short‑term relief of heightened anxiety symptoms. - Pre‑operative anxiety: helps calm patients before surgical procedures, facilitating smoother induction of anesthesia.

Bromazepam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or unsteadiness. - Impaired coordination: reduced motor control affecting balance. - Memory impairment: difficulty recalling recent events.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, especially with other depressants. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Dependence or withdrawal seizures: risk of physical dependence with prolonged use.

Bromazepam requires careful use in several clinical situations. - Dose adjustment in elderly: start with the lowest effective dose and monitor for excess sedation. - Avoid abrupt discontinuation: taper gradually under medical supervision to prevent withdrawal. - Use caution with hepatic impairment: monitor liver function and consider dose reduction. - Avoid concomitant CNS depressants: increased risk of profound sedation and respiratory depression. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Bromazepam can interact with a variety of medicines, altering its safety profile.

Major Interactions (Avoid): - Alcohol: additive central nervous system depression leading to severe sedation. - Opioids: synergistic respiratory depression and heightened risk of overdose. - Barbiturates: enhanced sedative effect and potential loss of consciousness.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): possible increase in serotonin syndrome risk. - Antihistamines: may intensify drowsiness and impair psychomotor performance.